Limited coverage criteria – leuprolide

Last updated on March 19, 2025

 

Return to Special Authority drug list 

Generic name

leuprolide

Special Authority criteria

Approval period

Diagnosis of precocious puberty

First approval: One year

Renewals: One year

Diagnosis of endometriosis First approval: Six months

Renewal: Six months

Diagnosis indicating need to reduce sexual drive Indefinite

Practitioner exemptions

  • Pediatric endocrinologists

Special notes

  • For (1) & (2) criteria applicable for all plans, excluding Plan G
  • For (3) criteria applicable for all plans, including Plan G
  • For any cancer-related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610

Special Authority request form(s)